Allegis Investment Advisors’s Pfizer PFE Stock Holding History

Allegis Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.18M	Sell	35,072 -3,590	-9%	-$123K	0.36%	66
2017 Q4	$1.33M	Sell	38,662 -39,601	-51%	-$1.35M	0.39%	73
2017 Q3	$2.65M	Buy	78,263 +6,803	+10%	+$219K	0.63%	42
2017 Q2	$2.28M	Buy	71,460 +4,756	+7%	+$150K	0.58%	47
2017 Q1	$2.17M	Buy	66,704 +12,373	+23%	+$390K	0.57%	43
2016 Q4	$1.67M	Buy	54,331 +11,331	+26%	+$346K	0.53%	56
2016 Q3	$1.38M	Buy	43,000 +7,961	+23%	+$266K	0.54%	66
2016 Q2	$1.16M	Buy	+35,039	New	+$1.12M	0.59%	62
2016 Q1	–	Sell	-3,310	Closed	-$101K	–	719
2015 Q4	$101K	Buy	+3,310	New	+$104K	0.06%	222

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allegis Investment Advisors's PFE Position: Q1 2018 in Review

Allegis Investment Advisors reduced its Pfizer (PFE) stake by 9.3% in Q1 2018, selling an estimated $123K and leaving 35,072 shares worth $1.18M. The position accounts for 0.36% of the portfolio, ranked #66.

Allegis Investment Advisors first reported a position in PFE in Q4 2015 and has held it in 9 quarters since. The position peaked at $2.65M in Q3 2017. 2,230 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Allegis Investment Advisors held 35,072 shares of Pfizer worth $1.18M as of Q1 2018.
Allegis Investment Advisors sold 3,590 Pfizer shares in Q1 2018, an estimated $123K.
Pfizer made up 0.36% of Allegis Investment Advisors's portfolio in Q1 2018, its #66 holding.
Allegis Investment Advisors first reported a position in Pfizer in Q4 2015 and has held it in 9 quarters since.
Allegis Investment Advisors's Pfizer position peaked at $2.65M in Q3 2017.
2,230 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.